Determinants of recovery from severe posterior reversible encephalopathy syndrome.

<h4>Objective</h4>Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES.<h4>Design</h4>70 patients with severe PRES admitted to 24 ICUs in 2001-2010 w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stephane Legriel, Olivier Schraub, Elie Azoulay, Philippe Hantson, Eric Magalhaes, Isaline Coquet, Cedric Bretonniere, Olivier Gilhodes, Nadia Anguel, Bruno Megarbane, Laurent Benayoun, David Schnell, Gaetan Plantefeve, Julien Charpentier, Laurent Argaud, Bruno Mourvillier, Arnaud Galbois, Ludivine Chalumeau-Lemoine, Michel Rivoal, François Durand, Arnaud Geffroy, Marc Simon, Annabelle Stoclin, Jean-Louis Pallot, Charlotte Arbelot, Martine Nyunga, Olivier Lesieur, Gilles Troché, Fabrice Bruneel, Yves-Sébastien Cordoliani, Jean-Pierre Bedos, Fernando Pico, Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS)
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7ef86b3eec5c4876bac1e56aee57fe7c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7ef86b3eec5c4876bac1e56aee57fe7c
record_format dspace
spelling oai:doaj.org-article:7ef86b3eec5c4876bac1e56aee57fe7c2021-11-18T07:05:33ZDeterminants of recovery from severe posterior reversible encephalopathy syndrome.1932-620310.1371/journal.pone.0044534https://doaj.org/article/7ef86b3eec5c4876bac1e56aee57fe7c2012-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0044534https://doaj.org/toc/1932-6203<h4>Objective</h4>Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES.<h4>Design</h4>70 patients with severe PRES admitted to 24 ICUs in 2001-2010 were included in a retrospective cohort study. The main outcome measure was a Glasgow Outcome Scale (GOS) of 5 (good recovery) on day 90.<h4>Main results</h4>Consciousness impairment was the most common clinical sign, occurring in 66 (94%) patients. Clinical seizures occurred in 57 (81%) patients. Median mean arterial pressure was 122 (105-143) mmHg on scene. Cerebral imaging abnormalities were bilateral (93%) and predominated in the parietal (93%) and occipital (86%) white matter. Median number of brain areas involved was 4 (3-5). Imaging abnormalities resolved in 43 (88%) patients. Ischaemic and/or haemorrhagic complications occurred in 7 (14%) patients. The most common causes were drug toxicity (44%) and hypertensive encephalopathy (41%). On day 90, 11 (16%) patients had died, 26 (37%) had marked functional impairments (GOS, 2 to 4), and 33 (56%) had a good recovery (GOS, 5). Factors independently associated with GOS<5 were highest glycaemia on day 1 (OR, 1.22; 95%CI, 1.02-1.45, p = 0.03) and time to causative-factor control (OR, 3.3; 95%CI, 1.04-10.46, p = 0.04), whereas GOS = 5 was associated with toxaemia of pregnancy (preeclampsia/eclampsia) (OR, 0.06; 95%CI, 0.01-0.38, p = 0.003).<h4>Conclusions</h4>By day 90 after admission for severe PRES, 44% of survivors had severe functional impairments. Highest glycaemia on day 1 and time to causative-factor control were strong early predictors of outcomes, suggesting areas for improvement.Stephane LegrielOlivier SchraubElie AzoulayPhilippe HantsonEric MagalhaesIsaline CoquetCedric BretonniereOlivier GilhodesNadia AnguelBruno MegarbaneLaurent BenayounDavid SchnellGaetan PlantefeveJulien CharpentierLaurent ArgaudBruno MourvillierArnaud GalboisLudivine Chalumeau-LemoineMichel RivoalFrançois DurandArnaud GeffroyMarc SimonAnnabelle StoclinJean-Louis PallotCharlotte ArbelotMartine NyungaOlivier LesieurGilles TrochéFabrice BruneelYves-Sébastien CordolianiJean-Pierre BedosFernando PicoCritically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS)Public Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 9, p e44534 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Stephane Legriel
Olivier Schraub
Elie Azoulay
Philippe Hantson
Eric Magalhaes
Isaline Coquet
Cedric Bretonniere
Olivier Gilhodes
Nadia Anguel
Bruno Megarbane
Laurent Benayoun
David Schnell
Gaetan Plantefeve
Julien Charpentier
Laurent Argaud
Bruno Mourvillier
Arnaud Galbois
Ludivine Chalumeau-Lemoine
Michel Rivoal
François Durand
Arnaud Geffroy
Marc Simon
Annabelle Stoclin
Jean-Louis Pallot
Charlotte Arbelot
Martine Nyunga
Olivier Lesieur
Gilles Troché
Fabrice Bruneel
Yves-Sébastien Cordoliani
Jean-Pierre Bedos
Fernando Pico
Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS)
Determinants of recovery from severe posterior reversible encephalopathy syndrome.
description <h4>Objective</h4>Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES.<h4>Design</h4>70 patients with severe PRES admitted to 24 ICUs in 2001-2010 were included in a retrospective cohort study. The main outcome measure was a Glasgow Outcome Scale (GOS) of 5 (good recovery) on day 90.<h4>Main results</h4>Consciousness impairment was the most common clinical sign, occurring in 66 (94%) patients. Clinical seizures occurred in 57 (81%) patients. Median mean arterial pressure was 122 (105-143) mmHg on scene. Cerebral imaging abnormalities were bilateral (93%) and predominated in the parietal (93%) and occipital (86%) white matter. Median number of brain areas involved was 4 (3-5). Imaging abnormalities resolved in 43 (88%) patients. Ischaemic and/or haemorrhagic complications occurred in 7 (14%) patients. The most common causes were drug toxicity (44%) and hypertensive encephalopathy (41%). On day 90, 11 (16%) patients had died, 26 (37%) had marked functional impairments (GOS, 2 to 4), and 33 (56%) had a good recovery (GOS, 5). Factors independently associated with GOS<5 were highest glycaemia on day 1 (OR, 1.22; 95%CI, 1.02-1.45, p = 0.03) and time to causative-factor control (OR, 3.3; 95%CI, 1.04-10.46, p = 0.04), whereas GOS = 5 was associated with toxaemia of pregnancy (preeclampsia/eclampsia) (OR, 0.06; 95%CI, 0.01-0.38, p = 0.003).<h4>Conclusions</h4>By day 90 after admission for severe PRES, 44% of survivors had severe functional impairments. Highest glycaemia on day 1 and time to causative-factor control were strong early predictors of outcomes, suggesting areas for improvement.
format article
author Stephane Legriel
Olivier Schraub
Elie Azoulay
Philippe Hantson
Eric Magalhaes
Isaline Coquet
Cedric Bretonniere
Olivier Gilhodes
Nadia Anguel
Bruno Megarbane
Laurent Benayoun
David Schnell
Gaetan Plantefeve
Julien Charpentier
Laurent Argaud
Bruno Mourvillier
Arnaud Galbois
Ludivine Chalumeau-Lemoine
Michel Rivoal
François Durand
Arnaud Geffroy
Marc Simon
Annabelle Stoclin
Jean-Louis Pallot
Charlotte Arbelot
Martine Nyunga
Olivier Lesieur
Gilles Troché
Fabrice Bruneel
Yves-Sébastien Cordoliani
Jean-Pierre Bedos
Fernando Pico
Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS)
author_facet Stephane Legriel
Olivier Schraub
Elie Azoulay
Philippe Hantson
Eric Magalhaes
Isaline Coquet
Cedric Bretonniere
Olivier Gilhodes
Nadia Anguel
Bruno Megarbane
Laurent Benayoun
David Schnell
Gaetan Plantefeve
Julien Charpentier
Laurent Argaud
Bruno Mourvillier
Arnaud Galbois
Ludivine Chalumeau-Lemoine
Michel Rivoal
François Durand
Arnaud Geffroy
Marc Simon
Annabelle Stoclin
Jean-Louis Pallot
Charlotte Arbelot
Martine Nyunga
Olivier Lesieur
Gilles Troché
Fabrice Bruneel
Yves-Sébastien Cordoliani
Jean-Pierre Bedos
Fernando Pico
Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS)
author_sort Stephane Legriel
title Determinants of recovery from severe posterior reversible encephalopathy syndrome.
title_short Determinants of recovery from severe posterior reversible encephalopathy syndrome.
title_full Determinants of recovery from severe posterior reversible encephalopathy syndrome.
title_fullStr Determinants of recovery from severe posterior reversible encephalopathy syndrome.
title_full_unstemmed Determinants of recovery from severe posterior reversible encephalopathy syndrome.
title_sort determinants of recovery from severe posterior reversible encephalopathy syndrome.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/7ef86b3eec5c4876bac1e56aee57fe7c
work_keys_str_mv AT stephanelegriel determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT olivierschraub determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT elieazoulay determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT philippehantson determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT ericmagalhaes determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT isalinecoquet determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT cedricbretonniere determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT oliviergilhodes determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT nadiaanguel determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT brunomegarbane determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT laurentbenayoun determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT davidschnell determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT gaetanplantefeve determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT juliencharpentier determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT laurentargaud determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT brunomourvillier determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT arnaudgalbois determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT ludivinechalumeaulemoine determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT michelrivoal determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT francoisdurand determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT arnaudgeffroy determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT marcsimon determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT annabellestoclin determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT jeanlouispallot determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT charlottearbelot determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT martinenyunga determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT olivierlesieur determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT gillestroche determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT fabricebruneel determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT yvessebastiencordoliani determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT jeanpierrebedos determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT fernandopico determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT criticallyiiiposteriorreversibleencephalopathysyndromestudygroupcypress determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
_version_ 1718423923820855296